Efficacy and Safety of BST-236 in Newly Diagnosed Acute Myeloid Leukemia Patients, Unfit for Standard Induction Therapy

Memorial Sloan Kettering Cancer Center New York, New York

Abramson Cancer Center, Philadelphia

Hollings Cancer Center, Charleston

Augusta University Georgia Cancer Center, Augusta

Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, Columbus

Franciscan Physician Network Oncology and Hematology Specialists, Indianapolis

University of Michigan Comprehensive Cancer Center, Ann Arbor

Rabin Medical Center, Petah Tikva

Northwestern Memorial Hospital, Chicago

Baylor Scott & White Research Institute Dallas Texas, Dallas

Rambam medical center hematology department, Haifa

Tel Aviv Sourasky Medical Center, Tel Aviv

Seattle Cancer Care Alliance, Seattle

West Virginia University, Morgantown

Soroka University Medical Center, Beersheba

Shaare Zedek Medical Center, Jerusalem